ストックスクリーナーアプリを入手
0.1928
0.94%
0.0018
プレマーケット:
.20
0.0072
+3.73%
前日終値:
$0.191
開ける：
$0.1923
24時間の取引高:
651.51K
Relative Volume:
0.07
時価総額：
$13.87M
収益：
-
当期純損益:
$-88.35M
株価収益率:
-0.144
EPS:
-1.3391
ネットキャッシュフロー:
$-81.07M
1週間 パフォーマンス:
+5.13%
1か月 パフォーマンス:
-43.53%
6か月 パフォーマンス:
-87.80%
1年 パフォーマンス:
-83.52%
1日の値動き範囲:
$0.191
$0.2081
1週間の範囲:
$0.17
$0.2199
52週間の値動き範囲:
$0.1402
$2.79
Io Biotech Inc Stock (IOBT) Company Profile
Compare IOBT vs VRTX, REGN, ALNY, ARGX, INSM
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IOBT
Io Biotech Inc
|
0.1928 | 13.74M | 0 | -88.35M | -81.07M | -1.3391 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Io Biotech Inc Stock (IOBT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-26 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2026-01-08 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2025-09-30 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-09-30 | ダウングレード | TD Cowen | Buy → Hold |
Io Biotech Inc (IOBT) 最新ニュース
Big Money Moves: Will IO Biotech Inc outperform tech stocksExit Point & Short-Term Trading Alerts - baoquankhu1.vn
Insider Trends: Whats the outlook for Samfine Creation Holdings Group Limiteds sectorTrade Risk Assessment & AI Forecasted Stock Moves - baoquankhu1.vn
IO Biotech (IOBT) to Release Quarterly Earnings on Monday - Defense World
Is Haverty Furniture Companies Inc part of any major index2026 PostEarnings & Real-Time Volume Triggers - baoquankhu1.vn
Here's why IO Biotech, Inc. (IOBT) looks ripe for bottom fishing - MSN
Layoff Tracker: Inovio Slims Down as Lead Asset Nears Market - BioSpace
IOBT Stock Price and Chart — NASDAQ:IOBT - TradingView
Market Overview: Is IO Biotech Inc stock a smart retirement pickEarnings Performance Report & Smart Swing Trading Techniques - baoquankhu1.vn
IO Biotech, Inc. (NASDAQ:IOBT) Sees Large Decline in Short Interest - Defense World
IOBT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
IOBT Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Portfolio Update: Is IO Biotech Inc stock a smart retirement pick2025 Support & Resistance & Consistent Profit Trading Strategies - baoquankhu1.vn
IO Biotech receives Nasdaq notice for bid price noncompliance - MSN
Is IO Biotech Inc. stock attractive for ETFs2025 Earnings Surprises & Low Risk Entry Point Tips - mfd.ru
Cancer Vaccines Competitive Landscape Report 2026: Comprehensive Insights About 250+ Companies and 300+ DrugsCollaborations and Licensing by Key Players Like Moderna, Merck, and IO Biotech - Yahoo Finance
Will IO Biotech Inc. outperform its industry peers2025 Key Lessons & Verified Chart Pattern Signals - mfd.ru
Chart Watch: Will IO Biotech Inc outperform tech stocksBuy Signal & Fast Exit Strategy with Risk Control - baoquankhu1.vn
IOBT Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
IOBT PE Ratio & Valuation, Is IOBT Overvalued - Intellectia AI
IO Biotech Faces Nasdaq Noncompliance, Potential Delisting Risk - The Globe and Mail
IO Biotech Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Nasdaq warns IO Biotech (NASDAQ: IOBT) on $50M market value rule - Stock Titan
Here's Why IO Biotech, Inc. (IOBT) Looks Ripe for Bottom Fishing - Finviz
Is IO Biotech Inc. a top pick in the sectorJuly 2025 Catalysts & Short-Term High Return Ideas - mfd.ru
Guidance Update: Is IO Biotech Inc in a consolidation phaseJuly 2025 PostEarnings & Safe Capital Growth Tips - baoquankhu1.vn
Point72 discloses 5.6% IO Biotech (IOBT) ownership stake - Stock Titan
Fierce Biotech Layoff Tracker 2026: ARPA-H makes cuts; GSK trims R&D team - Fierce Biotech
IO Biotech Provides Corporate Update - marketscreener.com
IO Biotech, Inc. (NASDAQ:IOBT) Receives Consensus Recommendation of “Reduce” from Analysts - Defense World
IO Biotech (IOBT) launches restructuring, CMO exit and up to $2.6M charges - Stock Titan
IO Biotech hires Raymond James as advisor, cuts workforce By Investing.com - Investing.com Canada
IO Biotech Engages Raymond James as Financial Advisor Amid Workforce Reduction and Cost-Containment Measures - Quiver Quantitative
Cancer vaccine maker IO Biotech cuts staff, hires Raymond James - Stock Titan
Piper downgrades IO Biotech amid strategic alternatives evaluation - Yahoo Finance
IO Biotech stock tumbles after Piper Sandler downgrades on strategic review By Investing.com - Investing.com South Africa
IO Biotech stock tumbles after Piper Sandler downgrades on strategic review - Investing.com South Africa
Piper Sandler Downgrades IO Biotech (IOBT) to Neutral, Lowers Pr - GuruFocus
Piper Sandler Downgrades IO Biotech to Neutral From Overweight, Adjusts Price Target to $0.50 From $3 - marketscreener.com
IO Biotech stock rating downgraded by Piper Sandler amid strategic review - Investing.com South Africa
IO Biotech, Inc. (IOBT) Upgraded to Buy: Here's Why - MSN
Aug Decliners: Is IO Biotech Inc a potential multi baggerMarket Growth Report & Entry and Exit Point Strategies - baoquankhu1.vn
IOBT IO Biotech, Inc. (NASDAQ) $0.47 on 22 Jan 2026: active intraday mover for traders - Meyka
IO Biotech’s Future Uncertain As Cylembio Cloud Remains - Citeline News & Insights
IO Biotech Begins Review Of Strategic Options As Cash Runway Narrows - Nasdaq
IO Biotech weighs strategic options months after FDA advises against melanoma vaccine filing - European Biotechnology Magazine
IO Biotech admits defeat | ApexOncoClinical Trials news and analysis - Oncology Pipeline
Listed Danish biotech company fights for survival after FDA rejection and failed capital raising - medwatch.com
IO Biotech (IOBT) Explores Strategic Alternatives, Stock Surges 19.36% - intellectia.ai
Biotech Stocks Surge After Hours: IO Biotech Jumps 19%, Cue Biopharma And Cabaletta Bio Follow - Nasdaq
IO Biotech stock plummets after company explores strategic alternatives By Investing.com - Investing.com Nigeria
Io Biotech Inc (IOBT) 財務データ
収益
当期純利益
現金流量
EPS
1.82%
大文字化:
|
ボリューム (24 時間):